The estimated Net Worth of John Glenn is at least $431 Thousand dollars as of 20 June 2023. Mr. Glenn owns over 5,795 units of Ekso Bionics Inc stock worth over $9,385 and over the last 6 years he sold EKSO stock worth over $23,863. In addition, he makes $397,424 as Chief Financial Officer at Ekso Bionics Inc.
John has made over 3 trades of the Ekso Bionics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 5,795 units of EKSO stock worth $6,556 on 20 June 2023.
The largest trade he's ever made was selling 10,292 units of Ekso Bionics Inc stock on 31 May 2019 worth over $14,100. On average, John trades about 1,504 units every 114 days since 2018. As of 20 June 2023 he still owns at least 8,295 units of Ekso Bionics Inc stock.
You can see the complete history of Mr. Glenn stock trades at the bottom of the page.
John F. Glenn serves as Chief Financial Officer of the Company. Mr. Glenn brings 25 years of financial leadership experience in public and private companies in the life sciences industry. Prior to joining us, Mr. Glenn was a consultant to biotechnology and medical device companies. From 2016 to 2017, Mr. Glenn served as the Chief Financial Officer of Sonendo Inc., a privately held, venture-backed company developing technology for dental root canal therapy. From 2015 to 2016, Mr. Glenn served as the Chief Financial Officer of Armetheon, Inc., a privately held biopharmaceutical company. From January 2008 to January 2014, Mr. Glenn served as the Chief Financial Officer of Solta Medical, Inc., where he assisted in the strategic acquisition by Valeant Pharmaceuticals International, Inc. of this then-Nasdaq-listed company that designed, developed, manufactured and marketed energy-based medical device systems for aesthetic applications. Mr. Glenn holds a Bachelor of Science degree in Business Administration from the University of Nevada and from the University of Santa Clara, a Master of Business Administration.
As the Chief Financial Officer of Ekso Bionics Inc, the total compensation of John Glenn at Ekso Bionics Inc is $397,424. There are 2 executives at Ekso Bionics Inc getting paid more, with Jack Peurach having the highest compensation of $660,604.
John Glenn is 57, he's been the Chief Financial Officer of Ekso Bionics Inc since 2019. There are 6 older and 5 younger executives at Ekso Bionics Inc. The oldest executive at Ekso Bionics Holdings Inc is Steven A. Sherman, 75, who is the Exec. Chairman.
John's mailing address filed with the SEC is C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS, FL, 32708.
Over the last 9 years, insiders at Ekso Bionics Inc have traded over $898,173 worth of Ekso Bionics Inc stock and bought 276,997 units worth $399,153 . The most active insiders traders include Theodore T Wang, Steven Sherman, and Russ Angold. On average, Ekso Bionics Inc executives and independent directors trade stock every 56 days with the average trade being worth of $25,243. The most recent stock trade was executed by Scott G. Davis on 17 August 2023, trading 37,446 units of EKSO stock currently worth $37,446.
since 2005, ekso bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. the company’s first commercially available product called ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. by designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, ekso bionics is helping people rethink current physical limitations and achieve the remarkable. ekso bionics is headquartered in richmond, california international offices: europe/middle east/africa 29th floor one canada square canary wharf london, united kingdom +44 20 7060 3568 kunden service deutschland +49 89 55067774
Ekso Bionics Inc executives and other stock owners filed with the SEC include: